Neurofibromatosis Clinic| Neurofibromatosis Clinic |
|
Clinic Overview The UAB Neurofibromatosis Clinic functions as a multidisciplinary team led by Dr. Bruce Korf and Dr. Lane Rutledge, who have extensive experience in caring for patients with this condition. Clinic staff include genetic counselors and nurses, as well as access to specialists as needed. The clinic serves patients and their families dealing with the lifelong medical, psychological, and social implications of this diagnosis. Involvement in clinical research or clinical trial is possible in some instances. For more information: Understanding Neurofibromatosis type 1 (NF1)Understanding Neurofibromatosis type 2 (NF2) Understanding Schwannomatosis Genetic Testing for NF Research Opportunities The University of Alabama at Birmingham (UAB) is launching a clinical trial for qualified individuals with a diagnosis of Neurofibromatosis type 1 (NF1). Ongoing studies: A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis type 1 related Plexiform Neurofibromas
In some instances, the normal clinic hours can be altered to accommodate a patient's or his or her family's schedule
|